These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27532279)

  • 21. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate and predictors of treatment prescription for hepatitis C.
    Butt AA; Justice AC; Skanderson M; Rigsby MO; Good CB; Kwoh CK
    Gut; 2007 Mar; 56(3):385-9. PubMed ID: 17005764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of response of US veterans to treatment for the hepatitis C virus.
    Backus LI; Boothroyd DB; Phillips BR; Mole LA
    Hepatology; 2007 Jul; 46(1):37-47. PubMed ID: 17567830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for hepatitis C.
    Med Lett Drugs Ther; 2012 Oct; 54(1401):81-2. PubMed ID: 23059420
    [No Abstract]   [Full Text] [Related]  

  • 25. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.
    Dominitz JA; Boyko EJ; Koepsell TD; Heagerty PJ; Maynard C; Sporleder JL; Stenhouse A; Kling MA; Hrushesky W; Zeilman C; Sontag S; Shah N; Ona F; Anand B; Subik M; Imperiale TF; Nakhle S; Ho SB; Bini EJ; Lockhart B; Ahmad J; Sasaki A; van der Linden B; Toro D; Martinez-Souss J; Huilgol V; Eisen S; Young KA
    Hepatology; 2005 Jan; 41(1):88-96. PubMed ID: 15619249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care.
    Backus LI; Belperio PS; Loomis TP; Yip GH; Mole LA
    JAMA Intern Med; 2013 Sep; 173(16):1549-52. PubMed ID: 23835865
    [No Abstract]   [Full Text] [Related]  

  • 28. New direct-acting antiviral medications are changing treatment of HIV/hepatitis C coinfection.
    Seybolt L
    HIV Clin; 2013; 25(4):1-5. PubMed ID: 24516913
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In brief: Hepatic injury with hepatitis C drugs.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529136
    [No Abstract]   [Full Text] [Related]  

  • 31. Studying new drugs for HCV. Excerpts from the FDA hearing.
    Huff B
    GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
    [No Abstract]   [Full Text] [Related]  

  • 32. New Merck and Vertex drugs raise standard of care in hepatitis C.
    Sheridan C
    Nat Biotechnol; 2011 Jul; 29(7):553-4. PubMed ID: 21747363
    [No Abstract]   [Full Text] [Related]  

  • 33. Trends in Timing of Dialysis Initiation within Versus Outside the Department of Veterans Affairs.
    Yu MK; O'Hare AM; Batten A; Sulc CA; Neely EL; Liu CF; Hebert PL
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1418-27. PubMed ID: 26206891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
    Hwang EW; Thomas IC; Cheung R; Backus LI
    J Clin Gastroenterol; 2013 Mar; 47(3):264-70. PubMed ID: 23269309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus.
    Aronsohn A; Reau N; Jensen D
    Hepatology; 2014 May; 59(5):1688-91. PubMed ID: 24806752
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C: a hidden, growing problem.
    Kennedy M
    WMJ; 2000 Aug; 99(5):24-5. PubMed ID: 11043065
    [No Abstract]   [Full Text] [Related]  

  • 37. Veterans' healthcare concerns: hepatitis C.
    Polzien G
    Home Healthc Nurse; 2007 May; 25(5):335-8; quiz 339-40. PubMed ID: 17495564
    [No Abstract]   [Full Text] [Related]  

  • 38. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
    ; Yee HS; Currie SL; Darling JM; Wright TL
    Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competition intensifies around hepatitis C.
    Dorey E
    Nat Biotechnol; 2009 Apr; 27(4):305-6. PubMed ID: 19352356
    [No Abstract]   [Full Text] [Related]  

  • 40. Guideline: New HCV drugs should go to sickest patients.
    Kuehn BM
    JAMA; 2014 Sep; 312(11):1084-5. PubMed ID: 25226461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.